Real-time enrollment status for this non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 4:03 PM UTC
| NCT Number | NCT03666000 |
| Recruiting Status | Recruiting |
| Condition | Non-Hodgkin Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 135 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Imugene Limited |
| Last Updated on CT.gov | February 2, 2026 (Feb 2, 2026) |
As of August 27, 2026: Clinical trial NCT03666000 is currently recruiting participants. This phase1 study for non-hodgkin lymphoma is actively seeking new participants at 18 locations across the United States. The study is sponsored by Imugene Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03666000 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03666000 was last updated Feb 2, 2026 (February 2, 2026). HelloStudys verifies this status automatically.